Buy Valeant Pharmaceuticals (VRX) Ahead of Investor Day Catalyst - Guggenheim

Go back to Buy Valeant Pharmaceuticals (VRX) Ahead of Investor Day Catalyst - Guggenheim

Form SC 13D/A Valeant Pharmaceuticals Filed by: Pershing Square Capital Management, L.P.

November 23, 2015 5:13 PM EST

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

... More